Consistent with this focus, laser therapy, VEGF inhibitors like bevacizumab (off-label), ranibizumab, aflibercept, and brolucizumab, and corticosteroids such as dexamethasone intravitreal implant comprise the current therapies for DRD [6,7,8]. The gene discussed is VEGFA; the disease is dystonia 5.